The pace of the growth is putting a premium on logistics capabilities, including distribution centers positioned to quickly reach U.S. customers.

Acquiring Roundup as part of the deal to take over Monsanto has embroiled Bayer in costly litigation over allegations the weedkiller causes cancer, a charge the company denies.

Lilly is looking to double its capacity to make drugs that mimic incretin, a hormone that gives the sensation of having eaten, by the end of the year.

CVS’s drugstore chain is coping with headwinds that include diminished concerns about the pandemic, which has translated into fewer visits for COVID-19 tests and vaccinations.

The country has so far relied almost solely on homegrown medicines and vaccines to shore up immunity and treat COVID patients. 

Access this e-book from Tecsys to learn about the advantages of a modern warehouse design process and the value of participation from all relevant parties.

Supply chains large and small are under siege by constant disruption. Companies find themselves struggling to serve customers, source materials, manage costs, handle supply constraints and shortages and, above all, gain visibility into what’s next.

With its new financing, TransVoyant will scale to reach new customers and expand its platform’s use cases.

The shortages are a reminder that volatile turns in demand and supply that have marked the pandemic are still undercutting some sectors.